BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 17336403)

  • 1. The PKC inhibitor, bisindolymaleimide, blocks DOI's attenuation of the effects of 8-OH-DPAT on female rat lordosis behavior.
    Selvamani A; Lincoln C; Uphouse L
    Behav Brain Res; 2007 Apr; 179(1):99-106. PubMed ID: 17336403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothalamic infusion of the 5-HT2/1C agonist, DOI, prevents the inhibitory actions of the 5-HT1A agonist, 8-OH-DPAT, on lordosis behavior.
    Uphouse L; Andrade M; Caldarola-Pastuszka M; Maswood S
    Pharmacol Biochem Behav; 1994 Mar; 47(3):467-70. PubMed ID: 8208763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors elevating cAMP attenuate the effects of 8-OH-DPAT on lordosis behavior.
    Uphouse L; Maswood S; Jackson A
    Pharmacol Biochem Behav; 2000 Jun; 66(2):383-8. PubMed ID: 10880694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone attenuates the effect of the 5-HT1A receptor agonist, 8-OH-DPAT, and of mild restraint on lordosis behavior.
    Truitt W; Harrison L; Guptarak J; White S; Hiegel C; Uphouse L
    Brain Res; 2003 Jun; 974(1-2):202-11. PubMed ID: 12742638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen-progesterone and 8-OH-DPAT attenuate the lordosis-inhibiting effects of the 5-HT1A agonist in the VMN.
    Uphouse L; Caldarola-Pastuszka M; Maswood S; Andrade M; Moore N
    Brain Res; 1994 Feb; 637(1-2):173-80. PubMed ID: 8180795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WAY100635 and female rat lordosis behavior.
    Uphouse L; Wolf A
    Brain Res; 2004 Jul; 1013(2):260-3. PubMed ID: 15193537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agonist activation of 5-HT1A receptors in the median raphe nucleus and female rat lordosis behavior.
    Uphouse L; Maswood S; Caldarola-Pastuszka M
    Brain Res; 1994 Dec; 668(1-2):271-5. PubMed ID: 7704614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced efficacy of 8-OH-DPAT's inhibition of lordosis behavior by prior estrogen treatment.
    Trevino A; Wolf A; Jackson A; Price T; Uphouse L
    Horm Behav; 1999 Jun; 35(3):215-23. PubMed ID: 10373334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prior treatment with estrogen attenuates the effects of the 5-HT1A agonist, 8-OH-DPAT, on lordosis behavior.
    Jackson A; Uphouse L
    Horm Behav; 1996 Jun; 30(2):145-52. PubMed ID: 8797023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of the 5-HT1A agonists, 5-hydroxy- and 5-methoxy-(3-di-n-propylamino)chroman, on female lordosis behavior.
    Uphouse L; Caldarola-Pastuszka M; Moore N
    Neuropharmacology; 1993 Jul; 32(7):641-51. PubMed ID: 8361579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional integration among 5-hydroxytryptamine receptor families in the control of female rat sexual behavior.
    Maswood N; Caldarola-Pastuszka M; Uphouse L
    Brain Res; 1998 Aug; 802(1-2):98-103. PubMed ID: 9748522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective actions of the 5-HT2A/2C receptor agonist, DOI, on 5-HT1A receptor-mediated inhibition of lordosis behavior.
    Maswood S; Andrade M; Caldarola-Pastuszka M; Uphouse L
    Neuropharmacology; 1996 Apr; 35(4):497-501. PubMed ID: 8793913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin receptor involvement in effects of restraint on female rat lordosis behavior.
    Uphouse L; Hiegel C; Perez E; Guptarak J
    Pharmacol Biochem Behav; 2007 Apr; 86(4):631-6. PubMed ID: 17368527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strain differences in the response to the 5-HT1A receptor agonist, 8-OH-DPAT.
    Uphouse L; Maswood S; Jackson A; Brown K; Prullage J; Myers T; Shaheen F
    Pharmacol Biochem Behav; 2002 Jun; 72(3):533-42. PubMed ID: 12175449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-dependent effects of estradiol benzoate on 5-HT1A receptor agonist action.
    Jackson A; Uphouse L
    Brain Res; 1998 Jun; 796(1-2):299-302. PubMed ID: 9689482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of the lordosis-inhibiting effects of 8-OH-DPAT by TFMPP and quipazine.
    Wolf A; Jackson A; Price T; Trevino A; Caldarola-Pastuszka M; Uphouse L
    Brain Res; 1998 Sep; 804(2):206-11. PubMed ID: 9757039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracerebral actions of the 5-HT1A agonists, 8-OH-DPAT and buspirone and of the 5-HT1A partial agonist/antagonist, NAN-190, on female sexual behavior.
    Uphouse L; Caldarola-Pastuszka M; Montanez S
    Neuropharmacology; 1992 Oct; 31(10):969-81. PubMed ID: 1436391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GABAA-5-HT1A receptor interaction in the mediobasal hypothalamus.
    Guptarak J; Selvamani A; Uphouse L
    Brain Res; 2004 Nov; 1027(1-2):144-50. PubMed ID: 15494165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-HT1A and muscarinic acetylcholine receptors jointly regulate passive avoidance behavior.
    Riekkinen P
    Eur J Pharmacol; 1994 Sep; 262(1-2):77-90. PubMed ID: 7813581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-HT1A receptor antagonists and lordosis behavior.
    Uphouse L; Andrade M; Caldarola-Pastuszka M; Jackson A
    Neuropharmacology; 1996 Apr; 35(4):489-95. PubMed ID: 8793912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.